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ABSTRACT
In Eukarya and Archaea, in addition to protein-only pseudouridine (Ψ) synthases, complexes containing one guide RNA and four
proteins can also produce Ψ. Cbf5 protein is the Ψ synthase in the complex. Previously, we showed that Ψ’s at positions 1940,
1942, and 2605 of Haloferax volcanii 23S rRNA are absent in a cbf5-deleted strain, and a plasmid-borne copy of cbf5 can
rescue the synthesis of these Ψ’s. Based on published reports of the structure of archaeal Cbf5 complexed with other proteins
and RNAs, we identified several potential residues and structures in H. volcanii Cbf5, which were expected to play important
roles in pseudouridylation. We mutated these structures and determined their effects on Ψ production at the three rRNA
positions under in vivo conditions. Mutations of several residues in the catalytic domain and certain residues in the thumb
loop either abolished Ψ’s or produced partial modification; the latter indicates a slower rate of Ψ formation. The universal
catalytic aspartate of Ψ synthases could be replaced by glutamate in Cbf5. A conserved histidine, which is common to Cbf5
and TruB is not needed, but another conserved histidine of Cbf5 is required for the in vivo RNA-guided Ψ formation. We also
identified a previously unreported novelty in the pseudouridylation activity of Cbf5 where a single stem–loop of a guide
H/ACA RNA is used to produce two closely placed Ψ’s and mutations of certain residues of Cbf5 abolished one of these two
Ψ’s. In summary, this first in vivo study identifies several structures of an archaeal Cbf5 protein that are important for its RNA-
guided pseudouridylation activity.
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INTRODUCTION
Pseudouridine (Ψ) is the most commonmodified nucleoside
found in different RNAs in all organisms (Charette and Gray
2000; Hamma and Ferré-D’Amaré 2006; Grosjean 2009;
Mueller and Ferré-D’Amaré 2009; Cantara et al. 2011). It is
a C5-ribosyl isomer of uridine (U) produced post-tran-
scriptionally. In comparison to U,Ψ can provide an addition-
al hydrogen bond and increased base stacking (Davis 1995;
Charette and Gray 2000; Hamma and Ferré-D’Amaré
2006). Ψ residues are common in functionally important re-
gions of RNAs, suggesting their possible roles in structure sta-
bilization and function of RNAs (Charette and Gray 2000;
Ofengand et al. 2001b; Decatur and Fournier 2002;
Lecointe et al. 2002; Namy et al. 2005; Baudin-Baillieu et
al. 2009; Karijolich and Yu 2010; Wu et al. 2011; Spenkuch
et al. 2014). New techniques have determined that Ψ is also
abundant in eukaryal mRNAs (Carlile et al. 2014; Lovejoy
et al. 2014; Schwartz et al. 2014; Li et al. 2015). Single- or
multi-site-specific single-protein Ψ synthases have been
recognized in all three domains of life. Based on sequence
similarities, these Ψ synthases have been classified into
six families: TruA, TruB, TruD, RluA, RsuA, and Pus10
(Mueller and Ferré-D’Amaré 2009; Spenkuch et al. 2014).
In addition to single-protein Ψ synthases, Eukarya and
Archaea have specific ribonucleoprotein (RNP) complexes
that can also produce Ψ at many sites in different cellular
RNAs (Kiss 2002; Decatur and Fournier 2003; Rozhdestven-
sky et al. 2003; Henras et al. 2004; Wang and Meier 2004;
Dennis and Omer 2005; Meier 2005; Yu et al. 2005; Matera
et al. 2007; Hamma and Ferré-D’Amaré 2010; Kiss et al.
2010; Watkins and Bohnsack 2012; Ge and Yu 2013). Each
complex contains a distinct box H/ACA guide RNA and
four core proteins. Cbf5 (Dyskerin in human and NAP57
in rodents) is the Ψ synthase in these complexes. The three
accessory proteins are Gar1, Nop10, and L7Ae (Nhp2 in
Eukarya). Several crystal structures of RNA-free and RNA-
bound forms of these complexes are now available
(Hamma et al. 2005; Li and Ye 2006; Manival et al. 2006;
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Rashid et al. 2006; Ye 2007; Duan et al. 2009; Liang et al.
2009; Li et al. 2011). The RNA component of the RNP
contains an internal loop, called the Ψ pocket, between two
double-stranded stem regions. Two strands of the Ψ pocket
pair with the target RNA on both sides of the U, which is con-
verted to Ψ. Guide RNAs can contain one to three of these
stem–loops. In box H/ACA RNAs, a highly conserved se-
quence, known as box ACA or box H (ANANNA), is situated
at the 3′-end of each stem–loop. These conserved sequences
are important for Cbf5 binding and formation of a stable
RNA–protein complex (Baker et al. 2005). Archaeal Cbf5
protein interacts with box H/ACA guide RNA, indepen-
dently of the other three core proteins (Baker et al. 2005;
Charpentier et al. 2005; Li and Ye 2006). Archaeal L7Ae pro-
tein interacts with a kink turn motif in the guide RNA to as-
sist with RNA folding (Hamma and Ferré-D’Amaré 2004).
L7Ae does not interact with the other three proteins in the
absence of the guide RNA (Hamma and Ferré-D’Amaré
2004).
Cbf5 belongs to the TruB family (Koonin 1996) of Ψ syn-
thases. Bacterial TruB (and Pus4, its eukaryal ortholog) pro-
duces Ψ55 in tRNAs in a guide RNA-independent manner.
Cbf5 has also been shown in vitro to produce Ψ55 in tRNAs
and some other Ψ in rRNAs in a guide RNA-independent
manner and this activity is enhanced by Gar1 and Nop10
(Roovers et al. 2006; Gurha et al. 2007; Muller et al. 2007,
2008; Kamalampeta and Kothe 2012). Based on the structural
and functional similarities of Cbf5 and TruB, certain com-
mon features about their mechanisms of RNA recognition
and action have been proposed. Cbf5 and TruB share a highly
conserved RNA-binding PUA (PseudoUridine synthase and
Archaeosine transglycosylase) domain, which is larger in
Cbf5 than in TruB (Li and Ye 2006; Manival et al. 2006;
Rashid et al. 2006; Ye 2007; Li 2008; Duan et al. 2009;
Hamma and Ferré-D’Amaré 2010). The PUA domain
of Cbf5 also has sequence and structural similarities with
two other RNA processing enzymes, Nip7p and archaeo-
sine transglycosylase (ArcTGT) (Rashid et al. 2006). The
ArcTGT PUA domain specifically contacts the 3′-terminal
CCA trinucleotides of the tRNA (Ishitani et al. 2003; Rashid
et al. 2006). This similarity and other structural studies have
suggested that the PUA domain of Cbf5 binds to the lower
stem and the 3′ ACA trinucleotides of box H/ACA RNA (Li
and Ye 2006; Rashid et al. 2006; Duan et al. 2009; Hamma
and Ferré-D’Amaré 2010). The accessory proteins Nop10
and Gar1 also help Cbf5 to bind to the specific structures of
the guide and target RNAs.
Both TruB and Cbf5 contain a thumb loop, which plays a
crucial role in substrate turnover (Hoang et al. 2005; Hamma
and Ferré-D’Amaré 2010), but their interactions are some-
what different. The thumb loop of Cbf5, also called the
β7_10 loop, is located between its β7 and β10 strands (Li
and Ye 2006; Liang et al. 2008, 2009; Duan et al. 2009;
Hamma and Ferré-D’Amaré 2010; Li et al. 2011). It interacts
with the Gar1 protein and the substrate RNA but not with the
guide RNA. It changes conformation during the activity of
the RNP. Its Gar1-bound conformation in the substrate-
free RNP is referred to as the open state and its substrate
RNA-bound state is referred to as the closed state.
Bacterial TruB positions U55 of tRNA to convert it to
Ψ55 by flipping the base out of the RNA helix (Hoang and
Ferré-D’Amaré 2001). The imidazole ring of a histidine in
TruB (His43 in Escherichia coli) occupies the space vacated
by the flipped-out uridine. This histidine is also conserved
in Cbf5. There is another conserved histidine in Cbf5, which
is not conserved in TruB. Both of these histidines have been
proposed to have certain roles in the activity of Cbf5 (Muller
et al. 2007; Duan et al. 2009; Liang et al. 2009; Hamma and
Ferré-D’Amaré 2010; Tillault et al. 2015b).
In the guide RNP complex, Nop10 interacts with Cbf5
along its entire length. Nop10 stabilizes the active-site struc-
ture of Cbf5 and the interface between the proteins contains
many highly conserved residues (Hamma et al. 2005; Manival
et al. 2006; Rashid et al. 2006; Hamma and Ferré-D’Amaré
2010). The N-terminal region of Cbf5 contains a highly con-
served region called Motif I (Hamma et al. 2005). It is well
conserved in other Ψ synthases and it is important for the
stability and function of Cbf5 (Koonin 1996; Spedaliere
et al. 2000). Motif I has certain conserved proline residues,
which form a structure called a “proline spine” with other
conserved prolines in Cbf5, Nop10, and L7Ae in the RNP
complex (Hamma and Ferré-D’Amaré 2010).
The gene encoding Cbf5 is essential in Eukarya (Jiang et al.
1993; Meier and Blobel 1994; Heiss et al. 1998; Phillips et al.
1998; Giordano et al. 1999; He et al. 2002), which may be due
to different roles of H/ACA RNPs in ribosome biogenesis,
mRNA splicing, and telomere maintenance (Meier 2005;
Karijolich and Yu 2008). The human homolog of Cbf5 is
called dyskerin. Several mutations and deletions in DKC1
(encoding dyskerin) cause the X-linked recessive disorder
dyskeratosis congenita (DC) (Ruggero et al. 2003; Mason
et al. 2005; Kirwan and Dokal 2008). The molecular basis
of DC is not yet clear. Both short telomeric repeats and dys-
functional rRNAs have been noticed in DC patients (Mitchell
et al. 1999).
Previously, by deleting the cbf5 gene in Haloferax volcanii,
we showed that the Cbf5 protein and Cbf5-mediated Ψ resi-
dues are not essential in this archaeon (Blaby et al. 2011). In
the present study, we used this deletion strain to express mu-
tants of H. volcanii Cbf5 (HvCbf5) for several residues and
structures that are predicted to interact with guide and target
RNAs, and H. volcanii Gar1 and Nop10 (HvGar1 and
HvNop10) proteins. The selection of residues and structures
for mutations was primarily based on the previous structural
studies done with Pyrococcus furiosus Cbf5, Gar1, and Nop10
(PfuCbf5, PfuGar1, and PfuNop10) proteins. We show here
that several structures of archaeal Cbf5 are essential, whereas
certain other structures are not. In addition, we also report
for the first time that archaeal Cbf5 can produce two closely
placed Ψ’s that are guided by the same single stem–loop of
H. volcanii Cbf5 in RNA-guided modification
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H/ACA RNA and that certain residues of Cbf5 are essential
for the production of one of these two Ψ’s.
RESULTS
Several structural and in vitro studies of Cbf5 protein have ei-
ther shown or predicted the importance of certain amino
acid residues and structures for the Ψ formation. Our objec-
tive was to determine the relevance of different conserved res-
idues and segments of archaeal Cbf5 in RNA-guided Ψ
formation under in vivo conditions where, in addition to in-
teractions within the RNP, other factors may also have some
role. Previously, we showed that Cbf5-mediated modifica-
tions were restored when HvCbf5 was expressed from a plas-
mid-encoded H. volcanii cbf5 gene in the Δcbf5 strain of H.
volcanii (Blaby et al. 2011). Here we used this system for
our objective. We expressed various mutants of HvCbf5 in
the Δcbf5 strain of H. volcanii and determined the presence
or absence of Cbf5-mediated Ψ in 23S rRNA of those cells.
Specific residues and structures of HvCbf5 selected for muta-
tions (mostly Ala substitutions) were based on the compara-
tive sequence alignment (Fig. 1) of Cbf5 proteins of several
organisms and a homology model of HvCbf5 based on the
available structure of PfuCbf5 (Fig. 2) as well as various re-
ports in the literature. Positions of the residues of HvCbf5 se-
lected for substitution mutations in this study are shown in
FIGURE 1. Multiple sequence alignment of archaeal and eukaryal Cbf5 proteins. Sequences represented here are from four Archaea: Haloferax vol-
canii (H. volcanii), Pyrococcus furiosus (P. furiosus),Methanocaldococcus jannaschii (M. jannaschii), and Sulfolobus solfataricus (S. solfataricus); and five
Eukarya: Saccharomyces cerevisiae (S. cerevisiae), Caenorhabditis elegans (C. elegans), Drosophila melanogaster (D. melanogaster), Arabidopsis thaliana
(A. thaliana), and Homo sapiens (H. sapiens). Secondary structural elements are marked above the sequences, with α-helices depicted as cylinders and
β-strands as arrows. Secondary structure of P. furiosus protein is based on the crystal structure (PDB 2EY4) (Rashid et al. 2006). Secondary structure of
H. volcanii protein is the resulting modeled structure from I-TASSER. One new secondary structural element for HvCbf5 was predicted by I-TASSER,
which is not shown in the cited reference (Rashid et al. 2006). The PUA domain regions comprising the structures at the two termini are marked by
green lines above the sequence. Thumb loop sequences are boxed in orange. The conserved catalytic aspartate (D) residue is enclosed within a red box.
Certain residues that differ between Archaea and Eukarya are enclosed in blue boxes. Residues used for mutagenesis in this study are indicated with red
asterisks above the sequence. Highly conserved residues (>80%) among all proteins are shaded in dark blue, and at least 60% conserved residues are
shown in medium blue. Light blue represents at least 40% conservation. Numbers after each sequence denote ending residues of each block.
Numbering of P. furiosus Cbf5 has been adjusted to match a previous report (Rashid et al. 2006), which is commonly used in the literature.
Numbers in parentheses indicate the length of the sequence not shown here.
Majumder et al.
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Figures 1, 2C and D. Results of the reactions are shown in
Figures 3–7 and Supplemental Figure S1 and are summarized
in Table 1.
The Ψ formation at positions 1940, 1942, and 2605 of the
23S rRNA of H. volcanii (E. coli positions 1915, 1917, and
2572) is guided by a box H/ACA sRNA (Blaby et al. 2011).
Two stem–loops of this sRNA have been proposed to guide
all three pseudouridylations, one for
Ψ2605 and the other one for both
Ψ1940 and Ψ1942 (Grosjean et al.
2008). Deletion of the gene for this box
H/ACA sRNA in H. volcanii abolishes
all three Ψ’s (M Majumder and R Gupta,
unpubl.). Interactions between the
sRNA and the target sites are shown in
Figure 3A. In this in vivo study, we
checked the effects of Cbf5 mutants on
Ψ formation at all three positions, i.e.,
at position 2605 for single modification
and at positions 1940 and 1942 for dou-
ble modification, to determine if the mu-
tants show different effects in the two
cases.
Sequence alignment and homology
model of HvCbf5
A multiple sequence alignment using se-
quences of HvCbf5 and the Cbf5 proteins
of several other archaeal and eukaryal or-
ganisms was created (Fig. 1). These pro-
teins contain the five conserved residues
observed in most Ψ synthases. These
residues are (i) a catalytic Asp, (ii) a basic
(Arg/Lys) residue, which forms a salt
bridge with the catalytic Asp, (iii) an aro-
matic (Tyr/Phe) residue, which stacks
close to the target uridine, orienting the
base for catalysis, (iv) a hydrophobic res-
idue, and (v) a Leu (McCleverty et al.
2007; Mueller and Ferré-D’Amaré 2009;
Hamma and Ferré-D’Amaré 2010).
The last two residues are involved in nu-
cleotide stacking and are not observed
in some Ψ synthases. Corresponding
HvCbf5 residues are D53, R151, Y81,
I150, and L170, respectively. The primary
sequence, GTLDPK (D is the catalytic
Asp) of the catalytic core is extremely
conserved, with the exception of S. solfa-
taricus, where catalytic Asp is replaced
by Glu. The thumb loop is highly con-
served in all proteins. HvCbf5 is shorter
than PfuCbf5 at both termini. Even
then, the two structures are nearly super-
imposable (Fig. 2A). HvCbf5 has a smaller PUA domain,
especially at the N terminus, when compared to its homologs.
Certain residues at homologous positions are different be-
tween archaeal and eukaryal Cbf5, but are similar among
members of each of the two domains of life. HvCbf5 residues
at several positions differ from those of other Archaea. This
may be a reflection of the internal environment ofH. volcanii.
FIGURE 2. Homology model of HvCbf5. (A) The structure of PfuCbf5 (red) has been extracted
from the Cbf5-Nop10-Gar1 crystal structure (PDB 2RFK) (Liang et al. 2007). The homology
model of HvCbf5 (tan) based on I-TASSER predicted structure is overlaid. (B) The HvCbf5 mod-
el structure from A is shown with thumb loop in blue and purple and the PUA domain in yellow.
The purple part of the thumb loop denotes the C loop (Ala115, Val116, and Ser117). The catalytic
Asp53 (red) and Cbf5 residues (Pro25, Pro28, and Pro54 in cyan) of the “proline spine” of the
RNP complex are shown as van der Waal’s spheres. (C) Model of HvCbf5 showing positions
of the residues that are individually substituted in this study. The α-carbons of these residues
are shown as colored spheres. The colors of these spheres are by residue type as defined in
VMD. Effects of Ala substitution of residues are indicated by colors of the labels: absence of
(red) or partial (yellow) modification at the three positions (1940, 1942, and 2605) of 23S
rRNA; partial modification at positions 1940 and 2605, but no modification at position 1942
(cyan); partial modification at position 1940, and normal modification at positions 1942 and
2605 (blue); and no effect (white), i.e., normal modification at all three positions. (See Table 1
for the effects of mutations of single and multiple residues of HvCbf5.) (D) Structural details
near the active site of HvCbf5. Most residues that affected activity of HvCbf5 after mutation
are shown. Colors of residues and labels are as in C.
H. volcanii Cbf5 in RNA-guided modification
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Halophilic Archaea have a very high concentration of K+ in
their cytoplasm, approaching saturation (Madern et al.
2000). HvCbf5 residues at certain positions (S29, S49,
L157, and S202) differ from other archaeal Cbf5, but are
the same as in eukaryal Cbf5. Interestingly, serines of dys-
kerin (human Cbf5) at positions homologous to HvCbf5
S49 and S202 are mutated in DC patients (Heiss et al.
1998; Knight et al. 1999).
Catalytic core residues of HvCbf5 that are conserved in
mostΨ synthases are responsible for Ψ formation at
positions 1940, 1942, and 2605 ofH. volcanii 23S rRNA
All five residues of HvCbf5 that are conserved in mostΨ syn-
thases were independently changed to Ala, and Ψ formation
at positions 1940, 1942, and 2605 of 23S rRNA of these trans-
formed strains was determined. Strains expressing D53A,
FIGURE 3. Ala substitutions of HvCbf5 residues conserved across allΨ synthases abolish or reduce Cbf5-mediatedΨ formation at the three positions
of 23S rRNA. (A) Interactions between the two H/ACA motifs of the sRNA and their 23S rRNA target sequences are shown. The two lines above the
sRNA indicate the sequences that pair to form the lower stem of the H/ACA RNA. H and ACA sequences are boxed. Regions of sRNAs above the Ψ
pocket are illustrated as stem–loops. Positions of the primers (arrows) HVLSUR1 and HVLSUR2 relative to rRNA sequences are shown. Positions of
Ψ’s (1940, 1942, and 2605) in the rRNA sequence are indicated. (B) U-specific analyses to determine themodification status of U1940 andU1942 of 23S
rRNA were done using primer HVLSUR1 (see panel A) and total RNA of Δcbf5 strain transformed with different mutant pHCbf5 plasmids (marked
above each panel). Lanes 1 and 2: Primer extensions on untreated RNA and on RNA following U-specific reactions, respectively. A dark band at a po-
sition in lane 2, but not in lane 1 indicates an unmodified U. Positions of certain U’s in 23S rRNA are indicated on the side. In WT cells, U1940 and
U1942 are converted toΨ, and U1936 (used as indicator for the positions) remains unmodified. (C) The primer and total RNA used in B are also used
for CMCT-primer extension analyses. Total RNAswere either untreated (−) or treated with CMCT (+) for the indicated time (inminutes), followed by
alkali (OH−) treatment (+) or no treatment (−). Positions of Cbf5-mediatedmodifications are indicated on the side. A dark band inCMCT followed by
alkali, in 10min and 20min lanes, indicatesΨ. (D,E) Analyses similar to those inB andC, respectively, using primerHVLSUR2 (see panelA), were done
to determine the modification status of U2605 of 23S rRNA. Unmodified U2604 and U2612 served as indicators for positions in D.
Majumder et al.
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I150A, R151A, and L170A did not show Ψ at any of the three
positions (Fig. 3C,E). Instead, these strains showed the pres-
ence of unmodified U at these positions (Table 1; Fig. 3B,D).
RNA of the strain containing the Y81A mutation showed the
presence of both Ψ and unmodified U at all three positions,
suggesting partial modification (Table 1; Fig. 3). Replacing
catalytic Asp (D53E) of HvCbf5 with Glu did not affect its ac-
tivity. It behaved like the WT protein under in vivo condi-
tions, producing Ψ at all three positions (Table 1; Fig. 3).
The histidine conserved in both Cbf5 and TruB is
not required for in vivo RNA-guided Ψ formation,
but another conserved histidine of Cbf5 is required
We mutated H31 and H48, two conserved His of HvCbf5.
Bacterial TruB contains a conserved His, homologous to
H48, but none corresponding to H31. The H31A mutation
abolished all threeΨ’s while the H48Amutation had no effect
on the Cbf5 activity (Table 1; Fig. 4).
The thumb loop of Cbf5 plays a major role
in RNA-guided Ψ formation
We deleted 16 residues (Q108-R123) of HvCbf5 to create a
ΔThumb loop mutant. This mutant did not produce Ψ at
any of the three positions (Table 1; Fig. 5). A structure at
the end of the thumb loop of PfuCbf5 is referred to as the
C loop (Liang et al. 2009). We created a mutant, ΔCloop,
where the corresponding region (A115, V116, and S117) of
HvCbf5 was deleted. This mutant also did not produce Ψ
at any of the three positions (Table 1; Fig. 5). However,
when we changed both V116 and S117 of the C loop to
Ala (retaining A115), the mutation (mCloop) had no
effect at Ψ production at any of the three positions (Table
1; Fig. 5).
We substituted the three consecutive residues (P110, P111,
and R112) of HvCbf5 that precede the C loop with Ala inde-
pendently and in different combinations. The results are
shown in Figure 6 and Table 1. Individually, P110A and
R112A did not show any defect in modification and P111A
only partially modified the three U’s. Mutating all three
FIGURE 4. Of the two conserved histidines of HvCbf5, H31 is required
but H48 is not for rRNA Ψ formation in vivo. Effects of Ala substitution
of conserved histidines (marked above each panel) of HvCbf5 for Ψ for-
mation at positions 1940, 1942, and 2605 were determined by primer
extensions following U-specific (A,C) and CMCT reactions (B,D).
The reactions were done as in Figure 3.
FIGURE 5. Proper structure of the thumb loop is important for the ac-
tivity of Cbf5. Effects of the mutations (marked above each panel) in the
thumb loop of HvCbf5 on Ψ formation at positions 1940, 1942, and
2605 were determined by primer extension following U-specific (A,C)
and CMCT (B,D) reactions. The reactions were done as in Figure 3.
H. volcanii Cbf5 in RNA-guided modification
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residues to Ala (PPR110-112AAA) abolished all three modi-
fications. Double mutants PP110-111AA and PR111-112AA,
where two consecutive residues were changed, abolished all
modifications. However, the P110R112AA mutant (where
P111 was not changed) abolished modification of U1942
but did not affect modifications of
U1940 and U2605. Ala substitution of
P111, either alone or in combination
with other mutations, in addition to af-
fecting the activity of HvCbf5 (Table 1;
Fig. 6), appears to reduce the amount of
the protein in the cell (cf. panels F and
G with panel B in Supplemental Fig. S2).
We also substituted the three consecu-
tive residues (R119, L120, and R121) of
HvCbf5 that are after the C loop, inde-
pendently with Ala. The results are
shown in Figure 6 and Supplemental
Figure S1 (panels E–H), and Table 1.
Residue R119 is Archaea specific.
R119A did not affect the modifications.
L120A showed partial modification of
U1940 but retained normal modification
of U1942 and U2605. R121A lost all
modifications.
Certain other residues of the catalytic
domain of Cbf5 are relevant for Ψ
formation
Mutations of certain residues of HvCbf5
that are adjacent to conserved residues
present in most Ψ synthases affected its
activity. Mutation of the Leu (L52A)
that precedes catalytic Asp showed partial
loss of modification at positions 1940
and 2605, and absence of modification
at position 1942 (Table 1; Fig. 7).
Mutation of Pro (P54A) that follows cat-
alytic Asp showed partial modification at
all three positions (Table 1; Fig. 7). There
is a conserved Tyr (Y149) that precedes
I150 and R151 of HvCbf5, the conserved
hydrophobic and basic residues ofΨ syn-
thases. Mutation of this Tyr (Y149A) also
showed partial modification at all three
positions (Table 1; Fig. 7). As expected
when all three residues Y149, I150, and
R151 were replaced with alanines, the
modifications were lost (Table 1; Fig.
7), because as mentioned, I150A and
R151A mutants did not show any
modification.
The C-terminal PUA domain is needed for Cbf5-
mediated Ψ formation
Both N- and C-terminal sequences of Cbf5 share parts of the
PUA domain, which holds the lower stem of the guide RNA.
FIGURE 6. Certain residues of the thumb loop are important for the guide RNA-dependent ac-
tivity of Cbf5. Effects of alanine substitution of some conserved residues (marked above each pan-
el) of the thumb loop of HvCbf5 for Ψ formation at positions 1940, 1942, and 2605 were
determined by primer extensions following U-specific (A,C) and CMCT reactions (B,D). The re-
actions were done as in Figure 3.
Majumder et al.
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Relative positions of the PUA domain and the Thumb loop of
HvCbf5 are shown in Figure 2. Deletion of the PUA domain
drastically reduces the in vitro activity of Cbf5 (Baker et al.
2005; Manival et al. 2006). We deleted the C-terminal PUA
domain (positions 217–289) of HvCbf5. As expected, this
abolishedΨ production at all three positions (Table 1; Fig. 7).
Individual mutations of several conserved Cbf5 residues
involved in interaction with Nop10 do not completely
abolish Ψ formation
Three prolines of HvCbf5, P25, P28, and P54 (P57, P60, and
P86, respectively, of PfuCbf5) form a part of the “proline
spine” (see Fig. 2B), which as mentioned before also includes
prolines of Nop10 and L7Ae in the RNP complex. P25 is
also expected to interact with certain conserved Pro residues
like P38 of HvNop10 (P32 of PfuNop10) (Hamma and Ferré-
D’Amaré 2010). Ala substitution of HvCbf5 P25 and P28 did
not have any effect on modification (Table 1; Supplemental
Fig. S1). This is similar to a yeast study where a mutant
(P67A of S. cerevisiae Cbf5) similar to P25A of HvCbf5 also
did not show any reduction of total Ψ content of rRNAs
(Zebarjadian et al. 1999). However, as mentioned, the third
Pro mutant (P54A) of HvCbf5 did show reduction in activity
(Table 1; Fig. 7).
Based on crystal structures, it is expected that K24 and
R171 of HvCbf5 (K56 and R204, respectively, of PfuCbf5)
would interact with Y20 and P38, respectively, of HvNop10
(Y14 and P32, respectively, of PfuNop10) (Hamma et al.
2005; Rashid et al. 2006). In vitro studies showed that Ala
substitutions of the corresponding residues in P. abyssi
Cbf5 (K53 and R202, respectively) significantly impaired
RNA-guided Ψ synthesis (Muller et al. 2007). However,
K24A and R171Amutants of HvCbf5 did not show any defect
in Ψ synthesis (Table 1; Supplemental Fig. S1). A conserved
Asp (D23) precedes K24 of HvCbf5. Yeast strains containing
Ala substitutions of corresponding Asp (D65, of S. cerevisiae
Cbf5, Fig. 1) showed a sharp reduction of total Ψ content of
rRNAs of the cells (Zebarjadian et al. 1999). The correspond-
ing D23A mutant did not affect Ψ formation at any of the
three positions (Table 1; Supplemental Fig. S1).
We also changed W36 and H169 of HvCbf5 to Ala.
PfuCbf5 contains conserved Trp (W69) and Glu (E202) at
corresponding positions (Fig. 1). These residues interact
with Nop10 (Li and Ye 2006). As shown in Figure 1, Trp is
conserved in all Cbf5, but His replaces the conserved Glu
in HvCbf5. W36A and H169Amutants of HvCbf5 did not af-
fect modification (Table 1; Supplemental Fig. S1).
Ala substitution of certain Archaea-specific charged
residues of HvCbf5 did not affect Ψ formation
Archaeal Cbf5 proteins share most of the domains andmotifs
with their eukaryal homologs. However, eukaryal Cbf5 is
larger than archaeal Cbf5 (Fig. 1). The eukaryal extensions
are beyond the N and C termini of the archaeal proteins.
These extensions may be reflections of multiple functions
of eukaryal Cbf5. There are certain residues at the homolo-
gous positions of archaeal and eukaryal proteins that are con-
served but the conservations between the two groups are
different, i.e., these are either Archaea specific or Eukarya
specific. These differences could be either due to multiple
functions of eukaryal Cbf5 or to accommodate interactions
with other accessory proteins, which may require some struc-
tural differences between Archaea and Eukarya. We selected
two residues, R119 (described before with thumb loop mu-
tants) and H155 of HvCbf5, which are charged residues in
Archaea but not charged (Gln and Val, respectively) in
Eukarya andmutated these to Ala. Neither of these mutations
affected Ψ synthesis at any of the three positions (Table 1;
Supplemental Fig. S1). We also changed R119 of HvCbf5
to Gln, its eukaryal counterpart, but we could not successfully
transform this R119Q mutant-containing plasmid into a
Δcbf5 strain in spite of multiple attempts.
Mutations of HvCbf5 corresponding to DKC1 mutations
causing dyskeratosis congenita do not abolish Ψ
modification
Mutations of DKC1 that cause DC are well dispersed on the
dyskerin structure (Mason et al. 2005). Most of the residues
involved in DC cluster in the N- and C-terminal extensions
of dyskerin that are not present in archaeal Cbf5 (Li et al.
2011). However, there are three residues (S121, S280, and
D369) within the central part of dyskerin that are mutated
in multiple families of DC patients (Heiss et al. 1998;
Knight et al. 1999). HvCbf5 has corresponding residues
(S49, S202, and D277, respectively). Surprisingly, the
HvCbf5 and dyskerin residues are identical at these three po-
sitions, whereas in PfuCbf5 (and other archaeal Cbf5)
residues at these positions are different. Dyskerin muta-
tions at these positions in DC patients are S121G, S280R,
and D369N. We changed the corresponding positions of
HvCbf5 to Ala (S49A, S202A, and D277A) as well as to those
observed in DC patients (S49G, S202R, and D277N). None of
these modifications affected Ψ formation at any of the three
positions (Table 1; Supplemental Fig. S1). This suggests that
thesemutations inDCpatients affect an activity or interaction
of dyskerin that might not be involved in Ψ synthesis.
DISCUSSION
Partial Ψ modifications in vivo may indicate an overall
slower rate of Ψ formation
Analyses of Ψ formation using primer extensions following
U-specific and CMCT reactions allow us to determine partial
modification at a specific position of rRNA. The cells showing
partial modification at a particular site would have ribosomes
containing two populations of 23S rRNA; one withΨ and the
H. volcanii Cbf5 in RNA-guided modification
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other having unmodified U at that site. We believe that partial
modifications indicate an overall slower rate of Ψ formation.
Our reasoning is that any particular rRNA modification
occurs in a short window of time between pre-rRNA tran-
scription and ribosome biogenesis. Therefore, an optimum
amount of specific modifying RNPs (or enzymes) has to be
available to modify all rRNAmolecules of the cell. We believe
that a slower rate of Ψ formation would effectively reduce
functioning RNPs that are available to modify all of the
rRNA molecules of the cell. This delay can occur at any stage
of Ψ formation, e.g., substrate recognition and its placement
in catalytic site, catalysis, or product release. We observed
partial modifications for L52A, P54A, Y81A, P111A, L120A,
and Y149Amutants of HvCbf5. L52 and P54 residues precede
and follow the catalytic D53 and probably provide optimum
conditions for Ψ formation. Ala substitution of Leu of yeast
Cbf5 (L94 of S. cerevisiae Cbf5, Fig. 1) corresponding to L52
of HvCbf5 also showed a sharp reduction of total Ψ in
rRNAs (Zebarjadian et al. 1999). P54 of HvCbf5 is the first
residue of the “proline spine” nearest to the catalytic Asp
and is in van der Waals interaction with P25 and P28 of
Motif I (Spedaliere et al. 2000; Hamma and Ferré-D’Amaré
2010), the other two Pro of the “proline spine” of Cbf5. The
“proline spine” probably provides a communication path
between the L7Ae protein and the active site of the Cbf5
(Hamma and Ferré-D’Amaré 2010). Correct positioning of
this Pro may enhance Ψ formation. Y81
is conserved in allΨ synthases and is pre-
dicted to stack close to the target uridine,
orienting the base for catalysis (Mueller
and Ferré-D’Amaré 2009; Hamma and
Ferré-D’Amaré 2010). P111 of the thumb
loop and Y149 (which precedes con-
served I150 and R151, present in other
Ψ synthases also) interact with each other
as well as with other residues of Cbf5 and
Gar1 and with the substrate RNA (Table
1). Conformations of Y149 are also differ-
ent under substrate-bound and substrate-
free states (see later). Partial Ψ modifica-
tion by mutations of these two residues
suggests that although not necessary,
these interactions help in proper place-
ment of the substrate and release of the
product. L120 of HvCbf5 (L153 of
PfuCbf5) is conserved in the thumb
loop of Cbf5 proteins. It is at the surface
that binds Gar1 in the open state of the
RNP (Duan et al. 2009). The mutant
L120A is somewhat unique. It showed
normal modification of U1942 and
U2605, but partial modification of
U1940 (Table 1; Fig. 6). When the corre-
sponding L153 of PfuCbf5 was changed
to Gly, it retained substantial in vitro ac-
tivity under single-turnover conditions, but showed only
∼25% activity under multiple-turnover conditions (Duan
et al. 2009). This suggests that the same structures of Cbf5
may be involved both in multiple turnover (in vitro) and in
multiple site (in vivo) activity.
Certain Cbf5 residues are specifically needed for one
of the two modifications guided by a single stem–loop
of H/ACA RNA
Asmentioned previously, the 5′ stem–loop of the box H/ACA
sRNA guides the formation of Ψ2605 and the 3′ stem–loop
guides bothΨ1940 andΨ1942, the last two modifications be-
ing the most conserved from bacteria to human. This case of
the same stem–loop converting two uridines of an RNA that
are close to each other is unique. A search of different s(no)
RNA databases indicates that there are several instances
where one stem–loop of a box H/ACA RNA can guide
more than one Ψ modification. However, in these cases,
the sites are either in two different RNAs or at two places
far apart in the same RNA. The two conserved modifications
of human and yeast large subunit rRNAs that correspond to
Ψ1940 and Ψ1942 of H. volcanii 23S rRNA (Ψ3741 and
Ψ3743 in human, Ψ2258 and Ψ2260 in yeast) are guided
by one box H/ACA RNA each (U19 in human, snR191 in
yeast) but by two separate stem–loops of these RNAs
FIGURE 7. Relevance of PUA domain and certain catalytic core residues of Cbf5 inΨ formation
in vivo. Effects of deletion of PUA domain and Ala substitution of certain conserved residues
(marked above each panel) of HvCbf5 for Ψ formation at positions 1940, 1942, and 2605 were
determined by primer extensions following U-specific (A,C) and CMCT reactions (B,D). The re-
actions were done as in Figure 3.
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TABLE 1. Summary of in vivo Ψ production at positions 1940, 1942, and 2605 of H. volcanii 23S rRNA using different mutants of HvCbf5
HvCbf5 mutant
PfuCbf5
residue
Predicted roles/characteristics in Cbf5 proteins
(residue numbers are of H. volcanii proteins)
Ψ
1940
Ψ
1942
Ψ
2605
Residues conserved in Ψ synthases (see Fig. 3)
D53A D85 Catalytic Asp residue − − −
D53E D85 + + +
Y81A Y113 Stacks close to the target uridine P P P
I150A I183 Involved in nucleotide stacking − − −
R151A R184 Forms salt bridge with catalytic Asp53 and hydrogen bond to isomerized
nucleotide
− − −
L170A L203 Involved in nucleotide stacking − − −
Conserved histidines (see Fig. 4)
H31A H63 Conserved in Cbf5, but not in TruB. Rotates over 90° between substrate-free
and substrate-bound RNP
− − −
H48A H80 Conserved in Cbf5 and TruB. Important for flipping out the base in tRNA
Ψ55 formation by TruB
+ + +
Thumb loop and its conserved residues (see Figs. 5, 6)
ΔThumb loop
(ΔQ108-R123)
ΔQ141-
R156
Highly conserved, interacts with substrate RNA and Gar1, involved in
substrate turnover
− − −
ΔCloop
(ΔAVS115-117)
ΔAVK 148–
150
Involved in docking of substrate RNA, interacts with Gar1 in the absence of
substrate RNA
− − −
mCloop (VS116-
117AA)
VK149-150 + + +
P110A P143 P110: Docks Gar1
P111: Interacts with Y149, substrate RNA and Docks Gar1 at V45
(P143, P144, and L145 of PfuCbf5 dock V23, V44, and L26 of PfuGarr1)
+ + +
P111A P144 P P P
R112A L145 + + +
PP110-111AA − − −
PR111-112AA − − −
P110R112AA + − +
PPR110-112AAA − − −
R121A R154 Interacts with Y149 through H-bonding and stacking in RNP, and also with
substrate RNA
− − −
L120A L153 Binds Gar1 in open state of RNP P + +
Conserved catalytic domain residues (see Fig. 7)
L52A L84 Precedes catalytic Asp, important in yeast P − P
P54A P86 Next to catalytic Asp, part of “proline spine,” van der Waals interaction with
P25 and P28
P P P
Y149A Y182 Conformation differs between substrate-free and substrate-bound RNP,
interacts with P111, R121, and Q108 (during closed state) of thumb loop
P P P
YIR149-151AAA YIR182-184 − − −
PUA domain (see Fig. 7)
ΔPUA (ΔH217-
V289)
Recognizes and binds to the lower stem and ACA of guide RNA − − −
Other residues (see Supplemental Fig. S1)
D23A D55 Important in yeast + + +
P25A P57 Part of “proline spine,” van der Waals interaction with P54, interacts with
P38 of Nop10
+ + +
P28A P60 Part of “proline spine,” van der Waals interaction with P54 + + +
K24A K56 Interacts with backbone of catalytic Asp and Y20 of Nop10 + + +
R171A R204 Interacts with P38 of Nop10 + + +
W36A W68 Interacts with Nop10 + + +
H169A E202 E202 of PfuCbf5 interacts with Nop10 + + +
R119A R152 In thumb loop, R in Archaea, Q in Eukarya + + +
H155A H188 Charged in Archaea, V in Eukarya + + +
S49A G81 Ser to Gly mutant dyskerin in some DC patients + + +
S49G + + +
S202A E237 Ser to Arg mutant dyskerin in some DC patients + + +
S202R + + +
D277A T316 Asp to Asn mutant dyskerin in some DC patients + + +
D277N + + +
(+) Ψ modification, (−) modification not detected, (P) partial modification.
H. volcanii Cbf5 in RNA-guided modification
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(Ganot et al. 1997; Bortolin and Kiss 1998; Badis et al. 2003),
not by a single stem–loop as in H. volcanii.
Twomutants of HvCbf5 (L52A and P110R112AA) showed
partial or nearly complete modification at position 1940 (and
position 2605) but no modification at position 1942 (Table
1). This suggested that these two modifications may occur
sequentially, i.e., Ψ1942 modification occurs only after the
production of Ψ1940. The target RNA, in this case, may be
recruited once and is released after formation of both Ψ’s,
or recruitment of the two target uridines may occur indepen-
dently of each other. In the latter case, U1942 is recruited
when the RNA contains Ψ1940. In both cases, U1942 is rec-
ognized in an unconventional manner and certain mutations
of HvCbf5 affect only this recognition. Residue L120 appears
to play some role in this recognition, because the above-men-
tioned L120A mutant shows partial modification at position
1940 but near normal modification at position 1942 (and po-
sition 2605). Specific features of the guide-target RNA inter-
actions (cf. two interactions shown in Fig. 3A) would also be
important in production of these double modifications. This
specific double modification activity of Cbf5 (or box H/ACA
RNPs) and the role of structural elements of Cbf5 in this ac-
tivity were not detected before our present study, because no
modification of two closely placed sites by a single stem–loop
was previously known.
Most predicted catalytic core residues are important
for Cbf5 activity
Four (D53, R151, I150, and L170) of the five conserved res-
idues of the catalytic core of the Ψ synthases are essential for
HvCbf5 activity because Ψ formation is abolished when
any one of these is individually substituted by Ala. Mutation
of the fifth residue (Y81A) showed partial modification.
Different mutants of Tyr of Pyrococcus proteins (Y113A,
Y113H, and Y113L of PfuCbf5, and Y110A and Y110F of P.
abyssi Cbf5) that correspond to Y81 of HvCbf5 also retained
some in vitro activity (Zhou et al. 2010; Tillault et al. 2015a).
Therefore, this nonessential but enhancing role of Y81 in Ψ
formation is somewhat surprising, because it (or another ar-
omatic residue) is conserved in all Ψ synthases.
All Cbf5 proteins contain a conserved Leu and Pro (L52
and P54 of HvCbf5) on two sides of the catalytic Asp
(D53) and a conserved Tyr (Y149 of HvCbf5) before the ad-
jacent hydrophobic and basic residues (I150 and R151) pres-
ent in most Ψ synthases (Fig. 1). The Pro is also part of the
“proline spine” (see Fig. 2B) and the Tyr also interacts with
certain residues of the thumb loop (Hamma and Ferré-
D’Amaré 2010). Individual Ala substitutions of all three res-
idues show partial modification (Table 1). Furthermore, as
mentioned above, the L52A mutant, although it partially
modified U1940 and U2605, did not show modification of
U1942. The Y182 of PfuCbf5, which corresponds to Y149
of HvCbf5, acquires two different conformations under sub-
strate-free and substrate-bound conditions and interacts with
conserved P144 and R154 (P111and R121 of HvCbf5) of the
thumb loop (Hamma and Ferré-D’Amaré 2010) and with
Q141 (Q108 of HvCbf5) during the closed state of the thumb
loop (Duan et al. 2009). Arg, His, and Ser mutation of Tyr182
of PfuCbf5 abolished enzymatic activity under in vitro con-
ditions, but an aromatic replacement (Y182F) only reduced
the activity (Zhou et al. 2010). Similarly, the Y179F mutant
of P. abyssi Cbf5 retained some in vitro activity and the
Y179A mutant almost lost this activity (Tillault et al.
2015a). Therefore, it appears that the residues of Cbf5 that
are adjacent to the conserved residues of Ψ synthases are
also important for the optimum activity of Cbf5.
A Cbf5 segment of nearly conserved residues GTYIR (po-
sitions 180–184 in PfuCbf5, 147–151 in HvCbf5, see Fig. 1),
which includes I150 and R151 is conserved in most Ψ syn-
thases, interacts with newly formed Ψ, and is suggested to
communicate the isomerization of U to the thumb loop
(and Gar1) for product release (Hamma and Ferré-
D’Amaré 2010). R151 forms a salt bridge with catalytic
D53, hydrogen bonds to Ψ, and signals the chemical change
in the catalytic site for product release. Furthermore, the con-
formation of Y149 in this segment shows a difference be-
tween substrate-free and bound RNP. Loss or reduction in
Ψ formation in Y149A, I150A, and R151A mutants of
HvCbf5 supports the communication role of this segment
of Cbf5.
The conserved catalytic aspartate of Ψ synthases
can be replaced by glutamate in Cbf5
As stated before, the conserved catalytic Asp observed in all
six families of Ψ synthases is replaced by Glu in S. solfataricus
(Fig. 1) and S. acidocaldarius (not shown). This Glu in Cbf5 is
not characteristic of the genus Sulfolobus or the kingdom
Crenarchaeota (to which Sulfolobus belongs) of the domain
Archaea. Cbf5 of Sulfolobus shibatae, Sulfolobus metallicus,
Sulfolobus tokodaii, and other members of the Crenarchaeota
contain Asp as the catalytic residue (data not shown).
Furthermore, there was no previous report that Glu-contain-
ing Cbf5 of S. Solfataricus or S. acidocaldarius do produce Ψ.
Conversion of catalytic Asp of PfuCbf5 to Glu also abolished
its activity under in vitro conditions (Zhou et al. 2010).
Therefore, the D53E mutant of HvCbf5 behaving like the
WT protein under in vivo conditions was surprising.
Although the physical structures of these two amino acids
are somewhat similar, nature has consistently selected Asp
as the catalytic residue in (nearly) all known Ψ synthases.
Roles of conserved histidines during in vivo RNA-guided
activity of archaeal Cbf5
Archaeal Cbf5 in vitro has been shown to have both RNA-
guided and guide RNA-independent pseudouridylation ac-
tivities (Baker et al. 2005; Charpentier et al. 2005; Roovers
et al. 2006; Gurha et al. 2007; Muller et al. 2007, 2008).
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Histidines equivalent to H31 andH48 of HvCbf5 play impor-
tant but distinct roles in these two activities (Muller et al.
2007; Duan et al. 2009; Liang et al. 2009; Hamma and
Ferré-D’Amaré 2010; Tillault et al. 2015b). Histidines com-
parable to H48 of HvCbf5 (H80 in PfuCbf5, H77 in
Pyrococcus abyssi Cbf5) are conserved both in Cbf5 and in
TruB (H43 of E. coli TruB). This His of TruB interacts with
the U54•A58 reverse Hoogsteen pair of tRNA and is critical
for flipping out the target U55 (Hoang and Ferré-D’Amaré
2001; Duan et al. 2009; Hamma and Ferré-D’Amaré 2010).
Though this His of Cbf5 has been suggested to have an inter-
action with the substrate U in guide RNA-dependent activity,
its confirmation does not change between the substrate-free
and substrate-bound H/ACA RNP (Hamma and Ferré-
D’Amaré 2010). The other His (H31 in HvCbf5, H63 in
PfuCbf5, H60 in P. abyssi Cbf5) that is conserved only in
Cbf5 interacts with a Watson-Crick pair formed between
guide and target RNA in RNA-mediated activity of Cbf5
(Duan et al. 2009; Liang et al. 2009). This second His may
also be involved in the RNA-independent conversion of
U55 to Ψ55 when the tRNA does not contain the U54•A58
reverse Hoogsteen pair (Gurha et al. 2007; Duan et al.
2009). Unlike the His common to both Cbf5 and TruB,
this particular His rotates over 90° from substrate-free to sub-
strate-bound state of the RNP during RNA-dependent activ-
ity of Cbf5 (Hamma and Ferré-D’Amaré 2010). Our results
agree with the importance of the Cbf5-specific histidine in
the RNA-dependent activity of Cbf5; the H31A mutation
abolishes all threeΨ’s in the rRNA (Table 1; Fig. 4). The other
His (H48), which is conserved in both Cbf5 and TruB, is not
important for in vivo RNA-dependent activity of Cbf5; all
three Ψ’s are present in the H48A mutant (Table 1; Fig. 4).
In agreement with our present in vivo study, previous in vitro
studies (Muller et al. 2007; Tillault et al. 2015b) showed that
H77A mutants of P. abyssi Cbf5 (similar to the H48A mutant
of HvCbf5) did not affect its guide RNA-dependent activity.
One of these studies also showed that H60, the other His of P.
abyssi Cbf5 (comparable to H31 of HvCbf5), is not essential
for either the RNA-independent or guide RNA-dependent
activity of Cbf5 (Tillault et al. 2015b). Our in vivo results
do not agree with their in vitro results for guide RNA-depen-
dent activity of Cbf5. We show here that this activity is abol-
ished in the comparable H31A mutant (Table 1; Fig. 4). It is
possible that one or the other His of Cbf5 may be important
for the guide RNA-independent activity of Cbf5 depending
on the structure of the substrate RNA (e.g., presence or
absence of U54•A58 reverse Hoogsteen pair in a tRNA).
Furthermore, the question may be raised whether under cer-
tain conditions (or for some substrates) the observed results
of in vitro activities of H/ACARNPsmay be a combination of
guide RNA-dependent and independent activities of Cbf5,
i.e., whether a particular substrate in vitro can be modified
by both activities of Cbf5. An in vivo study of RNA-indepen-
dent activity of Cbf5, if it occurs, may help in resolving some
of these issues.
Several residues of the thumb loop involved
in interactions with Gar1 and substrate RNA
are important for Cbf5 activity
The Thumb loop locks the target nucleotide at the active site
cleft. Residues near the closed end (tip) of this loop interact
with Gar1 in the substrate-free open state and dock the sub-
strate in the closed state (Duan et al. 2009; Liang et al. 2009;
Hamma and Ferré-D’Amaré 2010). In one publication, this
segment is referred to as the C loop, consisting of A148,
V149, and K150 of PfuCbf5 (Liang et al. 2009), correspond-
ing to HvCbf5 A115, V116, and S117 (Figs. 1, 2B). In another
publication, it is referred to as the tip of the thumb loop, con-
sisting of S147, A148, and V149 of PfuCbf5 (Duan et al.
2009), corresponding to HvCbf5 S114, A115, and V116.
Our results of ΔCloop and mCloop mutants (Table 1) indi-
cate that the exact size of the tip rather than its specific
sequence is essential for HvCbf5 activity. Interestingly,
the ΔCloop mutant of PfuCbf5, comparable to the ΔCloop
of HvCbf5, did not completely abolish in vitro Ψ formation
under single turnover conditions (Liang et al. 2009).
Residues preceding the tip (108–112 of HvCbf5) mainly
interact with Gar1 in the open state and flip over in the closed
state (Duan et al. 2009). Three consecutive residues P143,
P144, and L145 of PfuCbf5 dock at a hydrophobic patch
(V23, V44, and L26) of PfuGar1 (Li and Ye 2006). Only
two of the three residues are conserved in HvCbf5 (P110
and P111). The third HvCbf5 residue is a charged R112 in-
stead of the hydrophobic residue observed in other Cbf5 pro-
teins (Fig. 1). (HvGar1 residues that correspond to the
hydrophobic patch of PfuGar1 are T24, V45 and I27.) P144
of PfuCbf5 (P111 of HvCbf5) also interacts with Y182 of
PfuCbf5 (Y149 of HvCbf5) of the catalytic core region
through hydrogen bonding and stacking in the fully assem-
bled RNP and with substrate RNA through water-mediated
hydrogen bonding (Hamma and Ferré-D’Amaré 2010).
Although this Pro (P111) appears to be very important,
P110 and R112 do play some accessory roles. By itself,
P111A showed partial modifications, while P110A and
R112A did not affect modifications. However, P111A in
any combination with mutations of the other two residues
(PP110-111AA, PR111-112AA, and PPR110-112AAA) abol-
ished all modifications. Furthermore, mutant P110R112AA
(retaining P111) showed modification of U1940 (and
U2605) but not of U1942. This mutant is somewhat like
the above-mentioned L52Amutant that showed partial mod-
ification of U1940 but no modification of U1942.
Several basic residues after the tip (e.g., R119 and R121 in
HvCbf5) interact with phosphate groups of the substrate
RNA on the 5′ side of the target uridine (Duan et al. 2009;
Hamma and Ferré-D’Amaré 2010). R154 of PfuCbf5 (R121
of HvCbf5) also interacts with Y182 (Y149 of HvCbf5) of
the catalytic core region through hydrogen bonding and
stacking in the fully assembled RNP (Hamma and Ferré-
D’Amaré 2010). Although the R119A mutation did not affect
H. volcanii Cbf5 in RNA-guided modification
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modification, residue at this particular position must have
some special role in Eukarya (in other than H/ACA RNP ac-
tivity) because, as mentioned before, we did not succeed in
preparing H. volcanii strains that contained R119Q.
Eukaryal Cbf5 contains Gln instead of Archaea-specific Arg
at this position (see Fig. 1). Interactions of R121 (R154 of
PfuCbf5) must be essential because the R121A mutant lost
all modifications. Mutant R154Q of PfuCbf5 also lost all
activity under in vitro conditions (Duan et al. 2009). A con-
served Leu (L153 in PfuCbf5, L120 in HvCbf5) between the
two Arg (R119 and R121 of HvCbf5) is observed in Cbf5 pro-
teins. It is at the surface that binds to Gar1 in the open state of
the RNP (Duan et al. 2009). This Leu appears to have some
role during modification of U1940 and U1942, but not dur-
ing that of U2605. Mutant L120A showed normal modifica-
tion of U1942 and U2605, but no modification of U1940.
Most mutations of individual residues that form part
of an interacting surface of Cbf5 do not affect
its activity
Single mutations of individual residues of certain structures
or surfaces that are involved in intra- or intermolecular inter-
actions in general do not affect modifications, as we observed
for the mutants of the residues of the proline spine and of
those on the Cbf5 surface that interacts with Nop10 (Table
1). The Pro (P54 of HvCbf5, next to catalytic D53) at one
end of the proline spine stacks next to the flipped out base
of the residue 3′ to the target uridine of the substrate RNA,
and the Pro (of L7Ae) at the other end contacts the flipped
out uridine of the K-loop of the H/ACA guide RNA
(Hamma and Ferré-D’Amaré 2010). Mutation of P54
showed partial modification, but mutations of P25 and P28
did not affect modification. Probably, inside the cell, individ-
ual mutation of residues forming part of a structure either
slow downΨ formation or are compensated by accessory fac-
tors or other interactions. On the other hand, the identity of
the residues, whose chemical status or orientation changes
extensively during Ψ formation, appears to be essential.
This is the first report of an in vivo study of an archaeal box
H/ACA sRNP. By changing several residues and regions of
the Ψ synthase Cbf5, we identified several conserved residues
that are crucial for and others that facilitate the RNA-guided
activity of archaeal Cbf5. Furthermore, we also showed for
the first time that activities of archaeal Cbf5 are not identical
when it uses one stem–loop of guide RNA to modify only one
uridine and when it uses one stem–loop to modify two close-
ly placed uridines in a sequential manner. These differences
could be seen because mutations of certain residues abolished
only one of the two modifications.
MATERIALS AND METHODS
Standard molecular biology procedures (Sambrook and Russell
2001) were used unless specifically described.
Strains, media, and transformation procedures
H. volcanii H26 and VDC2364 (Blaby et al. 2011) were used as wild
type (WT) and cbf5-deleted (Δcbf5) strains. E. coli was routinely
grown in LB (Fisher) or LB agar (Fisher) at 37°C, supplemented
when required with ampicillin (100 µg/mL), chloramphenicol (34
µg/mL), IPTG (0.2 mM), and X-Gal (40 µg/mL). H. volcanii cells
were routinely grown at 42°C–44°C in Hv-YPC medium, as de-
scribed in the HaloHandbook (http://www.haloarchaea.com/
resources/halohandbook/Halohandbook_2008_v7.pdf) or in a me-
dium described previously (Gupta 1984), supplemented with novo-
biocin (0.8 µg/mL) when required. Transformation of H. volcanii
was performed as described before (Blaby et al. 2011).
Cloning and expression of wild type and mutants
of H. volcanii Cbf5 for in vivo analysis
Plasmid pHCbf5 (Blaby et al. 2011) was used to express WTHvCbf5
in H. volcanii. An ∼1000 bp HindIII-EcoRI fragment of pHCbf5
containing cbf5 was excised and recloned in pBluescript KS+
(Stratagene) to prepare the mutants of HvCbf5 in E. coli. Mutants
were created by site-directed mutagenesis. Oligonucleotides used
in this study are listed in Supplemental Table S1. After confirmation
of mutation by sequencing, the mutant HindIII-EcoRI fragment was
cut out from the plasmid and used to replace the correspondingWT
fragment of pHCbf5 for expression in H. volcanii. The sequence of
the mutant gene was again checked to ensure proper replacement of
the WT fragment. A commonly used system, e.g., D53A (Asp53
changed to Ala) and YIR149-151AAA (Tyr, Ile and Arg at positions
149–151 simultaneously changed to three Ala), was used to name
the substitution mutants.
The presence of mutant Cbf5 protein in every H. volcanii strain
that did not show Ψ at all three positions or had Ψ at positions
1940 and 2605 but not at position 1942 was checked by Western
blot analyses (see Supplemental Fig. S2). Antibody preparation
and these analyses are described in the Methods section of the Sup-
plemental Material.
Determination of the presence or absence of Ψ
at specific positions in 23S rRNA
All strains of H. volcanii were grown to A600 of approximately 1.0
and total RNA was isolated using Tri Reagent (Molecular
Research Center) according to manufacturer’s protocol. The pres-
ence of Ψ and its absence (the presence of unmodified U) in the
RNA was determined by primer extension following 1-cyclohexyl-
3-(2-morpholinoethyl) carbodiimide metho-p-toluenesulfonate
(CMCT) treatment (Ofengand et al. 2001a; Motorin et al. 2007)
and U-specific sequencing reaction (Peattie 1979; Gupta 1984), re-
spectively, as described previously (Blaby et al. 2011). Essentially,
CMCT reaction involves treatment of RNA with CMCT, ethanol
precipitation, alkali treatment, and ethanol precipitation again, fol-
lowed by primer extension. CMCT forms adducts with Ψ, U, and
G. Alkali removes all CMCT groups except those attached to N3
of Ψ (Bakin and Ofengand 1993). This method is not suitable for
quantitation of Ψ at a particular position in the RNA, because par-
tial reaction conditions are used here for the CMCT reactions.
Furthermore, reverse transcriptase reactions used for primer exten-
sions show varying amounts of sensitivity to secondary structures
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and different modified residues present in the RNA. Similarly, U-
specific reactions are also partial. Here uridines in RNA are hydra-
zinolysed using aqueous hydrazine followed by strand scission at
the position of damaged bases using acidified aniline. Both CMCT
and U-specific reactions were done on the same batch of RNA.
Reactions for the effects of each mutant protein were done at least
twice on the RNAs prepared from independent cell cultures harvest-
ed at different times. Results of repeat reactions were similar. We
consider Ψ present at a position in the RNA if a dark band is ob-
served at that position in the gel after CMCT but not after U-specific
reaction and absent when a dark band is observed after U-specific
but not after CMCT reaction. A band is considered “dark” when
its intensity is considerably more in the lane containing CMCT-
or hydrazine-treated RNA than the untreated RNA. Since these
primer extension reactions are not quantitative, we scored them as
partial Ψ production when dark bands were observed at a particular
position after both CMCT and U-specific reactions.
Multiple sequence alignment, homology modeling,
and bioinformatic analyses
Archaeal Cbf5 protein sequences were obtained from the UCSC
Archaeal Genome Browser (http://archaea.ucsc.edu/) and all other
(from yeast to human) sequences were obtained from the NCBI
protein database. Multiple sequence alignments of the Cbf5 protein
homologs were done in Clustal W (Larkin et al. 2007). The color-
coding in Figure 1 represents conservation of residues done by Jal-
view software (Waterhouse et al. 2009). Secondary structure and ho-
mology models ofH. volcanii Cbf5 were prepared using the I-Tasser
protein structure prediction suite (Zhang 2008; Roy et al. 2010; Yang
et al. 2015; Yang and Zhang 2015). In this pipeline, 10 template pro-
tein structures were identified by sequence and initially modeled us-
ing the LOMETS threading algorithm. These structures included
Pyrococcous furiosus Cbf5 (PDB accession code 2EY4) and H/ACA
ribonucleoprotein complex (2RFK; 2HVY), the Cbf5/NOP complex
in Methanococcus jannaschii (2APO), and the Cbf5-Nop10-Gar1
complex of Saccharomyces cerevisiae (3U28) as threading templates.
These templates had between 35% and 45% primary sequence iden-
tities compared to H. volcanii Cbf5. After threading the primary se-
quence of H. volcanii Cbf5 around these template structures, a
consensus centroid position for α-carbons and the side-chain center
of mass was calculated from the resulting lowest energy structures.
The model was then pipelined into the I-TASSER algorithm for
model refinement to determine lowest energy guided by RMSD
and steric clashes. The output-refined model was then assigned a
C-score based on RMSD in a consensus scoring of the multiple
threading templates, and a TM-score of structural similarity of the
final structure with the reference template structures. The refined
structure for our homology model ofH. volcanii Cbf5 had a C-score
of 1.13, indicating a high confidence model (typical reported range
is −5 to 2); a TM-score of 0.87 ± 0.07, indicating a model with the
correct topology (>0.5 is a typical cutoff); and an estimated RMSD
of 3.8 ± 2.6Å compared to reference Cbf5 models. Examination of
local accuracy estimates using ResQ (Yang et al. 2016) indicated
an accuracy of better than 2 Å for most residues except for a small
region (residues 111–119) where estimated accuracy was ∼10 Å.
Dihedral angles of the refined model were examined on a Rama-
chandran plot and compared to template structure (PDB 2RFK).
Secondary structures were within the most favored regions of the
plot or in similar locations as the template structure for most resi-
dues with the exception of one β strand (residues 137–144). This
final refined structure for H. volcanii Cbf5 was stored as a PDB
file, visualized in the Visual Molecular Dynamics (VMD) suite
(Humphrey et al. 1996), structurally aligned with P. furiosus Cbf5
using the MultiSeq extension (Roberts et al. 2006), and rendered us-
ing Tachyon (www.photonlimited.com/~johns/tachyon).
SUPPLEMENTAL MATERIAL
Supplemental material is available for this article.
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METHODS 
 
Western blot analyses to check the expression of inactive mutant HvCbf5 proteins 
 Custom made polyclonal rabbit antibodies (Cocalico Biologicals) against N-terminal His-tagged 
full-length HvCbf5 protein expressed in E. coli were used for Western analysis. For this purpose, H. 
volcanii cbf5 gene was cloned in a modified pET30a (Novagen) vector. The protein was expressed in E. 
coli Rosetta (DE3) pLysS (Novagen). The cells were grown to an A600 of approximately 0.6 and induced 
by 0.3 mM IPTG at 16°C for about 16 hr. Recombinant protein was purified by Nickel-affinity 
chromatography and then further separated by SDS-PAGE. A gel slice containing recombinant HvCbf5 
was used to raise antibodies. 1:4000 dilution of the third bleed was used for Western analysis. No 
commercial antibody against any H. volcanii protein is available. A band for an unidentified protein of 
about 55 kDa was always observed in cell extracts when we used anti-HvCbf5 antibody in our analyses. 
Its amount did not appear to vary in any strain containing mutant Cbf5. It was present even in the Δcbf5 
cells (Supplemental_Fig._S2, panel B). We used this protein as a loading control. H. volcanii cells from 
the same culture were used to prepare both Western blot to determine the presence of HvCbf5 in the cells 
and total RNA to determine the presence or absence of Ψ in 23S rRNA. For this purpose, a fraction of H. 
volcanii cell pellet was stored frozen every time total RNA was prepared. When the RNA did not show 
the presence of Ψ, corresponding frozen cells were used for Western analysis. In all such cases antibody 
detected HvCbf5 in cell extracts (Supplemental_Fig._S2). Quantitation of HvCbf5 protein in cell (band 
intensity relative to "control" protein of 55kDa) was done using ImageJ (1.47v). In most cases the amount 
of mutant protein in the cell was approximately the same as in the cell containing WT protein expressed 
from a plasmid-borne copy of the gene. This analysis does not tell whether the mutant protein folded into 
the correct conformation. 
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Supplementary Figure S1. Mutations of several residues (marked above each panel) of HvCbf5 did not 
affect Ψ formation at positions 1940, 1942 and 2605. Primer extensions analyses following U-specific (A, 
C, E, G, I and K) and CMCT reactions (B, D, F, H, J and L). The reactions were done as in Fig. 3. 
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Supplementary Figure S2. Western blot analyses to check the expression of inactive mutant HvCbf5. 
Analyses of proteins that either failed to modify U at any of the three positions (1940, 1942, and 2605) of 
23S rRNA or modified U1940 and U2605, but not U1942. Anti-HvCbf5 antibody was used to probe the 
blots. 10% polyacrylamide gels were used for SDS-PAGE. Each panel (A-I) is from an independent 
Western blot. (A) Recombinant protein used to raise antibodies. (B) Extracts of H. volcanii cells: WT - 
wild type, Δcbf5 - genomic cbf5 gene deleted, and Δcbf5+pHcbf5 - Δcbf5 containing plasmid-borne copy 
of WT cbf5 gene. (C-I) Extracts of Δcbf5 cells containing plasmid-borne copy of mutant cbf5 gene. 
Labels above each lane indicate the mutation. Positions of Cbf5 protein bands (full-length about 32 kDa) 
are marked with arrows. A band (marked with asterisks) for an unidentified protein (approximately 55 
kDa) was always observed in H. volcanii cell extracts. It is used here as a loading control and band 
intensity of HvCbf5 is calculated relative to this protein. Calculated amounts are indicated below each 
lane. (Calculations are not done for panels D and H, because transfer of proteins from the gel was not 
uniform.) 
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Supplementary Table S1 - List of Oligonucleotides used in this work and their functions 
 
 
Oligonucleotide               Sequence              Purpose 
 
In vivo assay for Catalytic core mutation 
 
 
VCBF-D53A-F 
CCC ACT CGG GAA CGC TCG 
CCC CGA AGG TGA CCG GCT G 
Forward primer to change catalytic 
Asp53 (GAC) of HvCbf5 gene to 
Ala (GCC) 
 
VCBF-D53A-R 
CAG CCG GTC ACC TTC GGG 
GCG AGC GTT CCC GAG TGG G 
Reverse primer to change catalytic 
Asp53 (GAC) of HvCbf5 gene to 
Ala (GCC) 
 
VCBF-Y81A-F 
CCT CGA AGG CTC GAA AGA 
GGC CGT CTC CGT GCT CGA 
ACT CCA C 
Forward primer to change Tyr81 
(TAC) of HvCbf5 gene to Ala 
(GCC) 
VCBF-Y81A-R IDT (10/11) GTG GAG TTC GAG CAC GGA 
GAC GGC CTC TTT CGA GCC 
TTC GAG G 
Forward primer to change Tyr81 
(TAC) of HvCbf5 gene to Ala 
(GCC) 
VCBF-I150A-F  IDT (10/11)   IDT (10/11) CTG TGA GTC GGG CAC GTA 
CGC CCG CAA GCT GTG TCA 
CGA CC 
Forward primer to change Ile150 
(ATC) of HvCbf5 gene to Ala 
(GCC) 
 
VCBF-I150A-R 
GGT CGT GAC ACA GCT TGC 
GGG CGT ACG TGC CCG ACT 
CAC AG 
 
Reverse primer to change Ile150 
(ATC) of HvCbf5 gene to Ala 
(GCC) 
VCBF-R151A-F   
 
 
GTG AGT CGG GCA CGT ACA 
TCG CCA AGC TGT GTC ACG 
ACC TCG G 
Forward primer to change Arg151 
(CGC) of HvCbf5 gene to Ala 
(GCC) 
VCBF-R151A-R   
 
 
CCG AGG TCG TGA CAC AGC 
TTG GCG ATG TAC GTG CCC 
GAC TCA C 
Reverse primer to change Arg151 
(CGC) of HvCbf5 gene to Ala 
(GCC) 
VCBF-L170A-F  IDT (10/11) GCG GCC ACA TGG GCC ACG 
CGC GCC GGA CCG CGA CCG AC 
Forward primer to change Leu170 
(CTG) of HvCbf5 gene to Ala 
(GCG) 
VCBF-L170A-R IDT (10/11) GTC GGT CGC GGT CCG GCG 
CGC GTG GCC CAT GTG GCC GC 
Reverse primer to change Leu170 
(CTG) of HvCbf5 gene to Ala 
(GCG) 
 
In vivo assay for RNA-Protein Interaction 
 
VCBF-D23A-F CGG CGT CGT CAA CCT CGC 
CAA GCC GCC GGG GC 
Forward primer to change Asp23 
(GAC) of HvCbf5 gene to Ala 
(GCC) 
VCBF-D23A-R GCC CCG GCG GCT TGG CGA 
GGT TGA CGA CGC CG 
Reverse primer to change Asp23 
(GAC) of HvCbf5 gene to Ala 
(GCC) 
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   VCBF-H31A-F   IDT (10/1 CGC CGG GGC CGT CGG CCG 
CCC AGG TCA CCG GCT GGG TC 
Forward primer to change 
His31(CAC) of HvCbf5 gene to 
Ala (GCC) 
VCBF-H31A-R GAC CCA GCC GGT GAC CTG 
GGC GGC CGA CGG CCC CGG CG 
Reverse primer to change 
His31(CAC) of HvCbf5 gene to 
Ala (GCC) 
VCBF-H48A-F GAC GTC GAC CGC GCC GCC 
GCC TCG GGA ACG CTC GAC 
CCG 
Forward primer to change His48 
(CAC) of HvCbf5 gene to Ala 
(GCC) 
VCBF-H48A-R CGG GTC GAG CGT TCC CGA 
GGC GGC GGC GCG GTC GAC 
GTC 
Reverse primer to change His48 
(CAC) of HvCbf5 gene to Ala 
(GCC) 
VCBF-L52A-F   
 
GCC CAC TCG GGA ACG GCC 
GAC CCG AAG GTG ACC 
Forward primer to change Leu52 
(CTC) of HvCbf5 gene to Ala 
(GCC) 
VCBF-L52A-R GGT CAC CTT CGG GTC GGC 
CGT TCC CGA GTG GGC 
Reverse primer to change Leu52 
(CTC) of HvCbf5 gene to Ala 
(GCC) 
 
VCBF-D53E-F 
CCC ACT CGG GAA CGC TCG 
AGC CGA AGG TGA CCG GCT G 
Forward primer to change catalytic 
Asp53 (GAC) of HvCbf5 gene to 
Ala (GCC) 
 
VCBF-D53E-R 
CAG CCG GTC ACC TTC GGC 
TCG AGC GTT CCC GAG TGG G 
Reverse primer to change catalytic 
Asp53 (GAC) of HvCbf5 gene to 
Ala (GCC) 
VCBF-Y149A-F CCG CTG TGA GTC GGG CAC 
GGC CAT CCG CAA GCT GTG 
TCA CG 
Forward primer to change Tyr149 
(TAC) of HvCbf5 gene to Ala 
(GCC) 
VCBF-Y149A-R CGT GAC ACA GCT TGC GGA 
TGG CCG TGC CCG ACT CAC 
AGC GG 
Reverse primer to change Tyr149 
(TAC) of HvCbf5 gene to Ala 
(GCC) 
VCBF-YIR149/51R CCG CTG TGA GTC GGG CAC 
GGC CGC CGC GAA GCT GTG 
TCA CGA CCT CGG CC  
Forward primer to change Tyr149, 
Ile150 and Arg151 
(TACATCCGC) of HvCbf5 gene 
to three Ala (GCCGCCGCG) 
VCBF-YIR149/51-R GGC CGA GGT CGT GAC ACA 
GCT TCG CGG CGG CCG TGC 
CCG ACT CAC AGC GG 
Reverse primer to change Tyr149, 
Ile150 and Arg151 
(TACATCCGC) of HvCbf5 gene 
to three Ala (GCCGCCGCG) 
   VCBFdPUA-F  IDT (2/13 CGC CCG CCG AGC GAG CGC 
TGT CGC ACC ATC ATC ATC 
ATC ATC ACT AGT GAG AAT 
TCC TGC 
Forward primer to delete PUA 
domain in  HvCbf5 gene already 
cloned in pBluescript KS+, 
contains His-tag 
  VCBFdPUA-R GCA GGA ATT CTC ACT AGT 
GAT GAT GAT GAT GAT GGT 
GCG ACA GCG CTC GCT CGG 
CGG GCG 
 
Reverse primer to delete PUA 
domain in  HvCbf5 gene already 
cloned in pBluescript  KS+, 
contains His-tag 
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Supplementary Table S1 (Continued) 
 
 
 
 
MJCBFdPUA-F  IDT (2/13) 
 
GTT ATA AAG CCA ATG GAG 
TAT GGG TTA AGG CAT AAG 
AGG AAG AAG TAA TGA ATT 
CGA GC 
Forward primer to delete PUA 
domain in M. jannaschii cbf5 gene 
already cloned in pET-28a 
MJCBFdPUA-R GCT CGA ATT CAT TAC TTC TTC 
CTC TTA TGC CTT AAC CCA TAC 
TCC ATT GGC TTT ATA AC 
Reverse primer to delete PUA 
domain in M. jannaschii cbf5 gene 
already cloned in pET-28a 
 
In vivo assay for Protein-Protein Interaction 
 
VCBF-K24A-F   IDT (3/13) GCG TCG TCA ACC TCG ACG 
CGC CGC CGG GGC CG 
 
Forward primer to change Lys24 
(AAG) of HvCbf5 gene to Ala 
(GCG) 
VCBF-K24A-R CGG CCC CGG CGG CGC GTC 
GAG GTT GAC GAC GC 
 
Reverse primer to change Lys24 
(AAG) of HvCbf5 gene to Ala 
(GCG) 
VCBF-P25A-F   IDT (10/11) CGT CGT CAA CCT CGA CAA 
GGC GCC GGG GCC GTC GGC CC 
 
Forward primer to change Pro25 
(CCG) of HvCbf5 gene to Ala 
(GCG) 
VCBF-P25A-R   IDT (10/11) IDT (10/11) 
 
GGG CCG ACG GCC CCG GCG 
CCT TGT CGA GGT TGA CGA CG 
 
Reverse primer to change Pro25 
(CCG) of HvCbf5 gene to Ala 
(GCG) 
VCBF-P28A-F CTC GAC AAG CCG CCG GGG 
GCG TCG GCC CAC CAG GTC 
ACC 
Forward primer to change Pro28 
(CCG) of HvCbf5gene to Ala 
(GCG) 
VCBF-P28A-R GGT GAC CTG GTG GGC CGA 
CGC CCC CGG CGG CTT GTC 
GAG 
Reverse primer to change Pro28 
(CCG) of HvCbf5 gene to Ala 
(GCG). 
VCBF-W36A-F 
 
CCA CCA GGT CAC CGG CGC 
GGT CCG CGA CAT GG 
Forward primer to change Trp36 
(TGG) of HvCbf5 gene to Ala 
(GCG) 
VCBF-W36A-R CCA TGT CGC GGA CCG CGC 
CGG TGA CCT GGT GG 
Reverse primer to change Trp36 
(TGG) of HvCbf5 gene to Ala 
(GCG) 
VCBF-P54A-F CCA CTC GGG AAC GCT CGA 
CGC GAA GGT GAC CGG CTG 
TCT ACC 
Forward primer to change Pro54 
(CCG) of HvCbf5gene to Ala 
(GCG) 
VCBF-P54A-R GGT AGA CAG CCG GTC ACC 
TTC GCG TCG AGC GTT CCC 
GAG TGG 
Reverse primer to change Pro54 
(CCG) of HvCbf5 gene to Ala 
(GCG) 
  VCBF-P110A-F  IDT (7/12) CGA AGC TCT ACC AGA AGG 
CCC CGC GGA AGT CCG C 
Forward primer to change Pro110 
(CCC) of HvCbf5 gene to Ala 
(GCC) 
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VCBF-P110A-R GCG GAC TTC CGC GGG GCC 
TTC TGG TAG AGC TTC G 
 
Reverse primer to change Pro110 
(CCC) of HvCbf5 gene to Ala 
(GCC) 
VCBF-P111A-F GCT CTA CCA GAA GCC CGC 
GCG GAA GTC CGC CGT CTC G 
Forward primer to change Pro111 
(CCG) of HvCbf5 gene to Ala 
(GCG) 
VCBF-P111A-R CGA GAC GGC GGA CTT CCG 
CGC GGG CTT CTG GTA GAG C 
Reverse primer to change Pro111 
(CCG) of HvCbf5 gene to Ala 
(GCG) 
 VCBF-R112A-F  IDT (7/12 CTA CCA GAA GCC CCC GGC 
GAA GTC CGC CGT CTC GC 
 
Forward primer to change Arg112 
(CGG) of HvCbf5 gene to Ala 
(GCG) 
VCBF-R112A-R GCG AGA CGG CGG ACT TCG 
CCG GGG GCT TCT GGT AG 
Reverse primer to change Arg112 
(CGG) of HvCbf5 gene to Ala 
(GCG) 
VCBF-PP 
110/11AA-F  IDT (7/12). 
CGA AGC TCT ACC AGA AGG 
CCG CGC GGA AGT CCG CCG 
TCT C 
Forward primer to change Pro110 
and Pro111 (CCCCCG) of HvCbf5 
gene to two Ala (GCCGCG) 
VCBF-PP 
110/11AA-R 
GAG ACG GCG GAC TTC CGC 
GCG GCC TTC TGG TAG AGC 
TTC G 
Reverse primer to change Pro110 
and Pro111 (CCCCCG) of HvCbf5 
gene to two Ala (GCCGCG) 
VCBF-
PR111/12AA-F 
GCT CTA CCA GAA GCC CGC 
GGC GAA GTC CGC CGT CTC GC 
Forward primer to change Pro111 
and Arg112 (CCGCGG) of 
HvCbf5 gene to two Ala 
(GCGGCG) 
VCBF-PR 
111/12AA-R 
GCG AGA CGG CGG ACT TCG 
CCG CGG GCT TCT GGT AGA GC 
Reverse primer to change Pro111 
and Arg112 (CCGCGG) of 
HvCbf5 gene to two Ala 
(GCGGCG) 
VCBF-PR 
110/12AA-F   IDT (9/12) 
CGA AGC TCT ACC AGA AGG 
CCC CGG CGA AGT CCG CCG 
TCT CGC 
Forward primer to change Pro110 
and Arg112 (CCC/CGG) of 
HvCbf5 gene to two Ala 
(GCC/GCG) 
VCBF-PR 
110/12AA-R 
GCG AGA CGG CGG ACT TCG 
CCG GGG CCT TCT GGT AGA 
GCT TCG 
Reverse primer to change Pro110 
and Arg112 (CCC/CGG) of 
HvCbf5 gene to two Ala 
(GCC/GCG) 
VCBF-PPR 
110/12A-F  IDT (4/12) 
CGA ATC GAA GCT CTA CCA 
GAA GGC CGC GGC GAA GTC 
CGC CGT CTC GCG C 
Forward primer to change Pro110, 
Pro111 and Arg112 
(CCCCCGCGG) of HvCbf5 gene 
to three Ala (GCCGCGGCG) 
VCBF-PPR 
110/12A-R 
GCG CGA GAC GGC GGA CTT 
CGC CGC GGC CTT CTG GTA 
GAG CTT CGA TTC G 
Reverse primer to change Pro110, 
Pro111 and Arg112 
(CCCCCGCGG) of HvCbf5 gene 
to three Ala (GCCGCGGCG) 
Majumder et al. 
 8 
Supplementary Table S1 (Continued) 
 
 
 
 
 
 
 
 
VCBF-d115/117-F   IDT (10/12). GCC CCC GCG GAA GTC CCG 
CCG CCT CCG CGT CCG 
Forward primer to delete aa 115-
117 (AVS) from HvCbf5 gene 
VCBF-d115/117-R CGG ACG CGG AGG CGG CGG 
GAC TTC CGC GGG GGC 
Reverse primer to delete aa 115-
117 (AVS) from HvCbf5 gene 
VCBF-VS 
116/17AA-F 
GCG GAA GTC CGC CGC CGC 
GCG CCG CCT CCG CG 
Forward primer to change Val116 
and Ser117 (GTCTCG) of HvCbf5 
gene to two Ala (GCCGCG) 
VCBF-VS 
116/17AA-R 
CGC GGA GGC GGC GCG CGG 
CGG CGG ACT TCC GC 
 
Reverse primer to change Val116 
and Ser117 (GTCTCG) of HvCbf5 
gene to two Ala (GCCGCG) 
  VCBF-L120A-F  IDT (4/12 CCG TCT CGC GCC GCG CCC 
GCG TCC GCG AAA TCC ACG 
Forward primer to change Leu120 
(CTC) of HvCbf5 gene to Ala 
(GCC) 
VCBF-L120A-R CGT GGA TTT CGC GGA CGC 
GGG CGC GGC GCG AGA CGG 
Reverse primer to change Leu120 
(CTC) of HvCbf5 gene to Ala 
(GCC) 
VCBF-R121A-F CCG TCT CGC GCC GCC TCG 
CGG TCC GCG AAA TCC ACG 
ACC 
Forward primer to change Arg121 
(CGC) of HvCbf5 gene to Ala 
(GCG) 
VCBF-R121A-R GGT CGT GGA TTT CGC GGA 
CCG CGA GGC GGC GCG AGA 
CGG 
Reverse primer to change Arg121 
(CGC) of HvCbf5 gene to Ala 
(GCG) 
  VCBF-H169A-F IDT (4/ GCG GCC ACA TGG GCG CCC 
TGC GCC GGA CCG C 
Forward primer to change His169 
(CAC) of HvCbf5 gene to Ala 
(GCC) 
VCBF-H169A-R GCG GTC CGG CGC AGG GCG 
CCC ATG TGG CCG C 
Reverse primer to change His169 
(CAC) of HvCbf5 gene to Ala 
(GCC) 
VCBF-R171A-F CCA CAT GGG CCA CCT GGC 
CCG GAC CGC GAC CG 
 
Forward primer to change Arg171 
(CGC) of HvCbf5 gene to Ala 
(GCC) 
VCBF-R171A-R CGG TCG CGG TCC GGG CCA 
GGT GGC CCA TGT GG 
Reverse primer to change Arg171 
(CGC) of HvCbf5 gene to Ala 
(GCC) 
VCBF-d108/123-F   IDT (7/11) CGC CGA GTT CGA ATC GAA 
GCT CTA CGA AAT CCA CGA 
CCT CGA CCT CC 
Forward primer to delete aa 108-
123 from HvCbf5 gene 
VCBF-d108/123-R GGA GGT CGA GGT CGT GGA 
TTT CGT AGA GCT TCG ATT 
CGA ACT CGG CG 
Reverse primer to delete aa 108-
123 from HvCbf5 gene 
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In vivo assay for DC mutations in Cbf5 
 
   
  VCBF-S49G-F2   IDT (3/12)   IDT (3/12) 
CGA CCG CGC CGC CCA CGG 
TGG AAC GCT CGA CCC G 
Forward primer to change Ser49 
( CG) of HvCbf5 gene to Gly 
(GGT) 
 
   VCBF-S49G-R2 
CGG GTC GAG CGT TCC ACC 
GTG GGC GGC GCG GTC G 
Reverse primer to change Ser49 
(TCG) of HvCbf5 gene to Gly 
(GGT) 
   
   VCBF-S49A-F   IDT (3/12) 
CGA CCG CGC CGC CCA CGC 
GGG AAC GCT CGA CCC G 
 
Forward primer to change Serine49 
( CG) of HvCbf5 gene to Ala 
(GCG) 
 
VCBF-S49A-R 
CGG GTC GAG CGT TCC CGC 
GTG GGC GGC GCG GTC G 
 
Reverse primer to change Serine49 
(TCG) of HvCbf5 gene to Ala 
(GCG) 
 
  VCBF-S202A-F   IDT (3/12) IDT (3/12) 
 
GCG GAG GGC GAC GAG GCG 
TGG CTG CGC GAC G 
Forward primer to change 
Serine20  (TCG) of HvCbf5 gene 
to Ala (GCG) 
 
VCBF-S202A-R 
CGT CGC GCA GCC ACG CCT 
CGT CGC CCT CCG C 
Reverse primer to change 
Serine202 (TCG) of HvCbf5 gene 
to Ala (GCG) 
 
VCBF-S202R-F 
GCG GAG GGC GAC GAG CGG 
TGG CTG CGC GAC G 
Forward primer to change 
Serine202 (TCG) of HvCbf5 gene 
to Arg (CGG) 
 
VCBF-S202R-R 
CGT CGC GCA GCC ACC GCT 
CGT CGC CCT CCG C 
Reverse primer to change 
Serine202 (TCG) of HvCbf5 gene 
to Arg (CGG) 
 
VCBF-D277A-F 
GGC GAC GCC GAC GCC GCC 
TCC GGC GAG GTC GTC TCG 
Forward primer to change Asp277 
(GAC) of HvCbf5 gene to Ala 
(GCC) 
VCBF-D277A-R 
 
 
CGA GAC GAC CTC GCC GGA 
GGC GGC GTC GGC GTC GCC 
 
Reverse primer to change Asp277 
(GAC) of HvCbf5 gene to Ala 
(GCC) 
  VCBF-D277N-F IDT (3/12) 
 
GGC GAC GCC GAC GCC AAC 
TCC GGC GAG GTC GTC TCG 
Forward primer to change Asp277 
(GAC) of HvCbf5 gene to Asn 
(AAC). 
 
VCBF-D277N-R 
CGA GAC GAC CTC GCC GGA 
GTT GGC GTC GGC GTC GCC 
 
Reverse primer to change Asp277 
(GAC) of HvCbf5 gene to Asn 
(AAC). 
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In vivo assay for residues found only in archaea 
 
VCBF-R119Q-F GTC CGC CGT CTC GCG CCA 
GCT CCG CGT CCG CGA AAT CC 
Forward primer to change Arg119 
(CGC) of HvCbf5 gene to Gln 
(CAG) 
 
VCBF-R119Q-R 
GGA TTT CGC GGA CGC GGA 
GCT GGC GCG AGA CGG CGG AC 
Reverse primer to change Arg119 
(CGC) of HvCbf5 gene to Gln 
(CAG) 
 
VCBF-R119A-F 
GTC CGC CGT CTC GCG CGC CCT 
CCG CGT CCG CGA AAT CC 
Forward primer to change Arg119 
(CGC) of HvCbf5 gene to Ala 
(GCC) 
 
VCBF-R119A-R 
GGA TTT CGC GGA CGC GGA 
GGG CGC GCG AGA CGG CGG AC 
Reverse primer to change Arg119 
(CGC) of HvCbf5 gene to Ala 
(GCC) 
 
 VCBF-H155A-F   IDT (7/12) 
 
GTA CAT CCG CAA GCT GTG 
TGC CGA CCT CGG CCT CGC 
GCT C 
Forward primer to change His155 
(CAC) of HvCbf5 gene to Ala 
(GCC) 
 
VCBF-H155A-R 
GAG CGC GAG GCC GAG GTC 
GGC ACA CAG CTT GCG GAT 
GTA C 
Reverse primer to change His155 
(CAC) of HvCbf5 gene to Ala 
(GCC) 
 
Primer extension 
 
 
HVLSUR1 
 
GCAAGGTACTACGCTACC 
To characterize Y1940 and  
Y1942 of 23S rRNA 
HVLSUR2 GCAGCCGACCTGTCTC To characterize Y2605 of 
23S rRNA 
